105 related articles for article (PubMed ID: 38732044)
1. PRKDC-Mediated NHEJ May Play a Crucial Role in Aneuploidy of Chromosome 8-Driven Progression of Ovarian Cancer.
Luan W; Cheng H; Xie H; Liu H; Wang Y; Wang S; Ye X; Zhu H; Tang F; Li Y; Chang X
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732044
[TBL] [Abstract][Full Text] [Related]
2. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
Gui T; Yao C; Jia B; Shen K
PLoS One; 2021; 16(6):e0253136. PubMed ID: 34143800
[TBL] [Abstract][Full Text] [Related]
3. Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3.
Ballabio S; Craparotta I; Paracchini L; Mannarino L; Corso S; Pezzotta MG; Vescio M; Fruscio R; Romualdi C; Dainese E; Ceppi L; Calura E; Pileggi S; Siravegna G; Pattini L; Martini P; Delle Marchette M; Mangioni C; Ardizzoia A; Pellegrino A; Landoni F; D'Incalci M; Beltrame L; Marchini S
Int J Cancer; 2019 Nov; 145(10):2670-2681. PubMed ID: 30892690
[TBL] [Abstract][Full Text] [Related]
4. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
5. WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use.
Chen Y; Tan X; Ding Y; Mai B; Huang X; Hu G; Luo X
Biomed Res Int; 2016; 2016():6594039. PubMed ID: 27190995
[TBL] [Abstract][Full Text] [Related]
6. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
7. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
8. Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma.
Goundiam O; Gestraud P; Popova T; De la Motte Rouge T; Fourchotte V; Gentien D; Hupé P; Becette V; Houdayer C; Roman-Roman S; Stern MH; Sastre-Garau X
Int J Cancer; 2015 Oct; 137(8):1890-900. PubMed ID: 25892415
[TBL] [Abstract][Full Text] [Related]
9. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles and pathway enrichment analysis to identification of differentially expressed gene and signaling pathways in epithelial ovarian cancer based on high-throughput RNA-seq data.
Siavoshi A; Taghizadeh M; Dookhe E; Piran M
Genomics; 2022 Jan; 114(1):161-170. PubMed ID: 34839022
[TBL] [Abstract][Full Text] [Related]
11. Chromosome instability region analysis and identification of the driver genes of the epithelial ovarian cancer cell lines A2780 and SKOV3.
Li J; Chen Z; Xiao W; Liang H; Liu Y; Hao W; Zhang Y; Wei F
J Cell Mol Med; 2023 Nov; 27(21):3259-3270. PubMed ID: 37525498
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.
Reid BM; Permuth JB; Chen YA; Fridley BL; Iversen ES; Chen Z; Jim H; Vierkant RA; Cunningham JM; Barnholtz-Sloan JS; Narod S; Risch H; Schildkraut JM; Goode EL; Monteiro AN; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1117-1126. PubMed ID: 30948450
[TBL] [Abstract][Full Text] [Related]
13. Single-cell analysis of copy-number alterations in serous ovarian cancer reveals substantial heterogeneity in both low- and high-grade tumors.
Kumar M; Bowers RR; Delaney JR
Cell Cycle; 2020 Nov; 19(22):3154-3166. PubMed ID: 33121339
[TBL] [Abstract][Full Text] [Related]
14. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin Gamma Catalytic Subunit PPP3CC Inhibition by miR-200c-3p Affects Apoptosis in Epithelial Ovarian Cancer.
Anastasiadou E; Messina E; Sanavia T; Labruna V; Ceccarelli S; Megiorni F; Gerini G; Pontecorvi P; Camero S; Perniola G; Venneri MA; Trivedi P; Lenzi A; Marchese C
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573382
[TBL] [Abstract][Full Text] [Related]
16. High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma.
Yamamoto A; Kurata M; Yamamoto K; Nogawa D; Inoue M; Ishibashi S; Ikeda M; Miyasaka N; Kitagawa M
Pathol Res Pract; 2020 Nov; 216(11):153175. PubMed ID: 32841774
[TBL] [Abstract][Full Text] [Related]
17. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression.
Du L; Li CR; He QF; Li XH; Yang LF; Zou Y; Yang ZX; Zhang D; Xing XW
Mol Med; 2020 Oct; 26(1):96. PubMed ID: 33109073
[TBL] [Abstract][Full Text] [Related]
19. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression.
Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
[TBL] [Abstract][Full Text] [Related]
20. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
